Characteristics | NNRTI-based regimen (n=138) | PI-based regimen (n=66) | p Value |
---|---|---|---|
Women, n (%) | 90 (65.2) | 39 (59.1) | 0.396 |
Mean age, years (SD) | 40.6 (8.7) | 42.5 (8.7) | 0.154 |
Mean body mass index, kg/m2 (SD) | 24.6 (4.7) | 23.8 (3.9) | 0.208 |
Median CD4 count, per mm3 (IQR) | 333 (206–459) | 330 (172–451) | 0.747 |
Median duration on ART, months (IQR) | 28 (13–40) | 36 (24–50) | 0.001 |
Median duration on NNRTI-based ART, months (IQR) | 28 (13–40) | 22 (10–36) | 0.001 |
Median duration on PI-based ART, months (IQR) | NA | 14 (12–20) | NA |
ART, antiretroviral therapy; NA, not applicable; NNRTI, non-nucleoside reverse transcriptase inhibitors; PI, protease inhibitors.